30.09.2025
Alithea Bio at CHI’s 17th Annual Immunogenicity & Bioassay Summit – Alexandria, VA, Oct 7–10, 2025
Alithea Bio is excited to announce that we will be attending CHI’s 17th Annual Immunogenicity & Bioassay Summit next week in Alexandria, Virginia. This premier U.S. event brings together top experts from the FDA, industry, and academia to discuss the latest strategies in immunogenicity risk assessment, preclinical and clinical development, and bioassay design and analysis.
Why Attend?
The summit provides a unique opportunity to:
Engage with leading scientists and regulatory authorities
Explore the latest innovations in immunogenicity and bioassays
Participate in interactive sessions, workshops, and short courses
Meet Alithea Bio
Visit our booth #3 to meet our team, learn about our cutting-edge solutions in immunopeptidomics and HLA profiling, and discuss how we help predict and mitigate immune responses early in the drug development pipeline.
Whether you are looking to overcome challenges in immunogenicity testing or enhance your bioanalytical strategy, this summit is the place to gain knowledge, build connections, and advance your programs.
We look forward to welcoming you at our booth in Alexandria, VA!
